[P.3.f.007] Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics

[P.3.f.007] Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics

2013 Eur. Neuropsychopharmacol

Vataire, A.L. | Ferchichi, S. | Desroziers, K. | Cadi-Soussi, N. | Murthy, V. | Toumi, M. | Volume: 25, Issue: Suppl 2, Pages: S495, Antipsychotic Agents, Cardiovascular Diseases, database analysis, Disease, Risk, Schizophrenia,